ANGO · NASDAQ
AngioDynamics (ANGO) Stock Price & Fundamentals
AngioDynamics (ANGO) closed at $664.42 on Oct 9, 2026, down 1.49% from the previous close of $674.45.
Share price, past year
1Y +2.93%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $664.42 |
| Sep 30, 2026 | $662.72 |
| Aug 31, 2026 | $668.48 |
| Jul 31, 2026 | $670.35 |
| Jun 30, 2026 | $649.21 |
| May 29, 2026 | $636.49 |
| Apr 30, 2026 | $607.67 |
| Mar 31, 2026 | $632.13 |
| Feb 27, 2026 | $623.40 |
| Jan 30, 2026 | $610.03 |
| Dec 31, 2025 | $659.34 |
| Nov 28, 2025 | $639.27 |
| Oct 31, 2025 | $655.16 |
Key statistics
- Market cap
- $28.19B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.79
- Revenue (TTM)
- $325.38M
- Net income (TTM)
- −$32.94M
- Shares outstanding
- 42.4M
- Dividend yield
- —
- 52-week range
- $600.54 – $704.82
AngioDynamics's market cap is $28.19B, based on a share price of $664.42 and 42.4M shares outstanding as of Aug 31, 2026.
Financials
AngioDynamics reported revenue of $320.17M for fiscal 2026, up 9.46% from fiscal 2025.
AngioDynamics reported a net loss of $36.74M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended May 31, 2026 | $320.17M | +9.5% | −$36.74M | −11.5% | −$0.88 | $508.00K |
| FY2025ended May 31, 2025 | $292.50M | −3.8% | −$33.99M | −11.6% | −$0.83 | −$14.59M |
| FY2024ended May 31, 2024 | $303.91M | −10.3% | −$184.35M | −60.7% | −$4.59 | −$30.68M |
| FY2023ended May 31, 2023 | $338.75M | +7.1% | −$52.44M | −15.5% | −$1.33 | −$3.73M |
| FY2022ended May 31, 2022 | $316.22M | +8.7% | −$26.55M | −8.4% | −$0.68 | −$11.49M |
| FY2021ended May 31, 2021 | $291.01M | +10.2% | −$31.55M | −10.8% | −$0.82 | $18.91M |
| FY2020ended May 31, 2020 | $264.16M | −2.4% | −$166.79M | −63.1% | −$4.39 | −$21.79M |
| FY2019ended May 31, 2019 | $270.63M | +3.4% | $61.34M | 22.7% | $1.64 | $34.32M |
| FY2018ended May 31, 2018 | $261.66M | −3.0% | $16.34M | 6.2% | $0.44 | $38.90M |
| FY2017ended May 31, 2017 | $269.79M | — | $5.01M | 1.9% | $0.14 | $52.74M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Aug 31, 2026 | $80.92M | −$7.10M | −$0.17 |
| Q4 FY2026ended May 31, 2026 | $86.61M | −$11.41M | −$0.28 |
| Q3 FY2026ended Feb 28, 2026 | $78.42M | −$8.08M | −$0.19 |
| Q2 FY2026ended Nov 30, 2025 | $79.43M | −$6.35M | −$0.15 |
| Q1 FY2026ended Aug 31, 2025 | $75.71M | −$10.90M | −$0.26 |
| Q4 FY2025ended May 31, 2025 | $80.16M | −$6.05M | −$0.15 |
| Q3 FY2025ended Feb 28, 2025 | $72.00M | −$4.41M | −$0.11 |
| Q2 FY2025ended Nov 30, 2024 | $72.85M | −$10.74M | −$0.26 |
Company profile
- Name
- AngioDynamics, Inc.
- Ticker
- ANGO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 14 Plaza Drive, Latham, NY 12110
- Incorporated in
- DE
- Fiscal year ends
- May
- SEC CIK
- 0001275187
Recent SEC filings
- Oct 8, 2026
- Oct 8, 2026
- Oct 8, 2026
- Sep 29, 2026
- Sep 29, 2026
- Jul 14, 2026
- Jul 14, 2026
- Apr 23, 2026
Frequently asked questions
What is AngioDynamics's stock price?
AngioDynamics (ANGO) closed at $664.42 on Oct 9, 2026, down 1.49% from the previous close of $674.45.
What is AngioDynamics's market cap?
AngioDynamics's market cap is $28.19B, based on a share price of $664.42 and 42.4M shares outstanding as of Aug 31, 2026.
How much revenue does AngioDynamics make?
AngioDynamics reported revenue of $320.17M for fiscal 2026, up 9.46% from fiscal 2025.
Does AngioDynamics pay a dividend?
AngioDynamics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from AngioDynamics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures